Tandem Diabetes Care (TNDM): Company Cash Volume

Official company branding of Tandem Diabetes (TNDM)

The dynamics of insulin system updates and software integrations are driving growth, as evidenced by the company's cash asset movements. Tandem Diabetes Care revenues are based on the sale of smart pumps and associated consumables. However, competition from GLP-1 drugs and pressure from insurers create margin risks. The current liquidity volume 0.44 determines this parameter level, confirming the business's financial stability.

Company Cash Funds: Tandem Corp (TNDM) for 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Tandem Diabetes Care Inc (TNDM)

- stock quotes and analyst forecast:
Initial company analysis:Tandem Corp TNDM
Brand item of Tandem Diabetes Care, Inc.

This indicator aggregates cash and cash equivalents to determine the business's ability to cover capital expenditures without resorting to expensive external debt. By analyzing the cash reserves of Tandem Diabetes Care (TNDM), an investor assesses the resilience of the Control-IQ ecosystem: a sufficient liquidity buffer guarantees the development of proprietary software and protects the business from degradation during the aggressive scaling of medical solutions.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume AXGN (Axogen Surgical)|Company Cash Funds si-bone.com|Company Cash on Hand Orthofix Medical Inc. (OFIX)|Company Cash Funds Bioventus Corp (BVS)|KIDS - Company Cash Reserve|Company Cash Funds Treace Medical Concepts TMCI|SRTA: Company Cash and Cash Equivalents|CARL: Company Cash on Hand|rxsight.com - Company Total Cash Amount|CLPT: Company Cash Volume|STXS - Company Liquid Assets|STIM (neurostar.com) - Company Cash Volume|Sight Sciences, Inc (SGHT) - Company Liquid Assets|Company Cash Volume OBIO|Company Liquid Assets Anika Therapeutics Inc.|Company Cash Funds InspireMD, Inc. NSPR|Company Cash Balance ZJYL|VANI - Company Cash Funds|Xtant Medical Holdings, Inc. - Company Total Cash Amount|NeuroOne (NMTC) - Company Cash Funds|Modular Med (MODD) - Company Cash Volume|Company Cash Funds Myomo, Inc|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)